Navegação por título
Itens para a visualização no momento 1281-1300 of 2964
-
Household Transmission of SARS-CoV-2
(2020-03-21)[Abstract]. Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused an epidemic in China and many other countries. Many infected clusters have been found within familial households, but the data ... -
How and when to end the COVID-19 lockdown: an optimisation approach
(2020-05-02)Countries around the world are in a state of lockdown to help limit the spread of SARS-CoV-2. However, as the number of new daily confirmed cases begins to decrease, governments must decide how to release their populations ... -
How best to use limited tests? Improving COVID-19 surveillance in long-term care
(2020-04-22)Background: Long-term care facilities (LTCFs) are particularly vulnerable to nosocomial outbreaks of coronavirus disease 2019 (COVID-19), with high rates of transmission and mortality. Timely epidemiological surveillance ... -
How Big Data and Artificial Intelligence Can Help Better Manage the COVID-19 Pandemic
(2020-05-02)SARS-CoV2 is a novel coronavirus, responsible for the COVID-19 pandemic declared by the World Health Organization. Thanks to the latest advancements in the field of molecular and computational techniques and information ... -
How can pandemic spreads be contained in care homes?
(2020-04-14)Care home settings serve a primarily elderly population with a diverse range of medical requirements. Care homes are unique in being both health-related institutions and people’s home. In available data the risk of dying ... -
How is COVID-19 affecting South Korea? What is our current strategy?
(2020-04-03)The outbreak of coronavirus disease 2019 (COVID-19) caused by the virus SARS-CoV-2 is expanding globally. South Korea is one of the countries most affected by COVID-19 from the very early stages of this pandemic. Explosive ... -
How many are at increased risk of severe COVID-19 disease? Rapid global, regional and national estimates for 202
(2020-04-22)Background The risk of severe COVID-19 disease is known to be higher in older individuals and those with underlying health conditions. Understanding the number of individuals at increased risk of severe COVID-19 illness, ... -
How the COVID-19 pandemic changed the Plastic Surgery activity in a regional referral center in Northern Italy
(2020-05-09)The Covid 19 epidemic has modified the way that plastic surgeons can treat their patients. At our hospital all elective surgery was canceled and only the more severe cases were admitted. The outpatient department activity ... -
How the COVID-19 pandemic is favoring the adoption of digital technologies in healthcare: a literature review
(2020-05-18)Background. Healthcare is responding to the COVID-19 pandemic through the fast adoption of digital solutions and advanced technology tools. The aim of this study is to describe which digital solutions have been reported ... -
How to avoid nosocomial spread during tracheostomy for COVID‐19 patients
(2020-04-16)To the editor, As the novel coronavirus (COVID‐19) globally spreads, the COVID‐19 pandemic is straining health‐care workers worldwide. In hospitalized patients with severe COVID‐19 infection, endotracheal intubation is one ... -
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Tria
(2020-03-20)Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2, and reported to be efficient in Chinese COV-19 patients. We evaluate the role of hydroxychloroquine on respiratory viral loads. Patients and ... -
Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients
(2020-05-08)Background: COVID-19 has rapidly emerged as a pandemic infection that has caused significant mortality and economic losses. Potential therapies and means of prophylaxis against COVID-19 are urgently needed to combat this ... -
Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19
(2020-05-01)Importance: Coronavirus disease 2019 (COVID-19) is a pandemic with no specific drugs and high mortality. The most urgent thing is to find effective treatments. Objective: To determine whether hydroxychloroquine application ... -
Hydroxychloroquine in COVID-19: A systematic review and meta-analysis
(2020-05-20)Abstract Background Hydroxychloroquine is being administered among patients with COVID19 infection in many healthcare systems across the world considering its in vitro effect against the SARS CoV 2 virus. In spite of several ... -
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019
(2020-05-14)Objective To assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19). Design Multicentre, open label, randomised ... -
Hydroxychloroquine safety: A meta-analysis of randomized controlled trials
(2020-07-06)Background: Hydroxychloroquine (HCQ) is currently being examined for COVID-19. No previous meta-analysis has evaluated its side effects versus placebo. We conducted this meta-analysis to compare the safety of HCQ versus ... -
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
(2020-07-03)BACKGROUND Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited. METHODS We conducted a ... -
Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic
(2020-04)Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past seventy years [1]. These agents have attracted intense media attention ...